Technology | March 11, 2009

Navilyst Highlights Power Injectable Port, PICC, Infusion Set at SIR

Xcela Power Injectable Port catheter for long-term delivery of fluids and medications including chemotherapy.

Xcela Power Injectable Port catheter for long-term delivery of fluids and medications including chemotherapy.

Xcela Power Injectable Port catheter for long-term delivery of fluids and medications including chemotherapy.

March 11, 2009 - Navilyst Medical is highlighting recently released products that included PICC Convenience Kitting, Xcela Power Injectable Port catheter for long-term delivery of fluids and medications including chemotherapy, and the EZ Huber Safety Infusion Set, which offers a dual-action safety mechanism designed to reduce the risk of bloodborne pathogen exposure.

The products provide clinicians and hospitals the catheter and accessory choices they require for a procedure that is efficient and conducive to reducing the risk of accidental needlesticks (OSHA) and infections (CDC and Joint Commission). This also reduces costs from unnecessary supplies, the company said.

The company expanded its customized PICC Convenience Kit to include the new Xcela Power Injectable PICC and a wider array of PICC insertion accessories and packaging. The titanium Xcela ports, available in standard and low profile sizes, offer durability and reduced size for ease of implantation and patient comfort, the company claims. The plastic Xcela ports are lightweight for patient comfort and offer radiolucence-reduced imaging artifact. The plastic/titanium hybrid port design option combines the durability of titanium with the lightweight and radiolucence of plastic. All designs have a 5mL/sec with 300 psi infusion rating for use in contrast imaging procedures

Navilyst Medical’s new EZ Huber Safety Infusion Set offers a dual-action safety mechanism designed to reduce the risk of bloodborne pathogen exposure that threatens clinician safety and is a significant cost to the healthcare system. One safety feature shields the tip of the needle after the needle is withdrawn from the patient to prevent accidental needle sticks. The second safety feature is a protective cover that surrounds the entire needle after withdrawal to reduce exposure to aerosolized or splattered infusion fluids and blood.
The EZ Huber Safety Infusion Set is compatible with Navilyst Medical’s new Xcela Power Injectable Port and is rated for up to 5mL/sec at 300 psi for contrast-enhanced CT imaging procedures.

For more information: www.navilystmedical.com

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Philips Launches IntraSight Interventional Applications Platform
Technology | Interventional Radiology | May 20, 2019
Philips announced the launch of the new IntraSight interventional applications platform. The secure, application-based...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Magnetic Resonance Imaging (MRI) | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
Clinical Trial Explores Opening Blood-Brain Barrier in Fight Against Alzheimer's

Vibhor Krishna, M.D., (right) fits David Shorr with a helmet-like device used in a new clinical trial for Alzheimer’s disease at The Ohio State University Wexner Medical Center. The device uses MRI-guided imaging to deliver focused ultrasound to specific areas of the brain to open the blood-brain barrier. Image courtesy of Ohio State University Wexner Medical Center.

News | Focused Ultrasound Therapy | May 09, 2019
May 9, 2019 — A new clinical trial at The Ohio State University Wexner Medical Center and two other sites is testing
Ultrasonic Device Safe and Effective for Lung Vessel Sealing in Minimally Invasive Lobectomy
News | Interventional Radiology | May 06, 2019
According to a new study, an ultrasonic vessel-sealing device can improve patient outcomes by reducing the incidence of...
360 degree view inside an Interventional radiology lab at Henry Ford Hospital used for neuro-interventions and stroke.
360 Photos | 360 View Photos | May 06, 2019
This is a 360 degree photo view inside the neuro-interventional radiology lab at ...
Multisociety Position Statement Endorses Prostatic Artery Embolization
News | Interventional Radiology | May 02, 2019
A new position statement from interventional radiology professional societies in the U.S. and Europe states that...
Mentice and RAD-AID Collaborate to Improve Access to Interventional Radiology in Resource-constrained Regions
News | Interventional Radiology | April 22, 2019
April 22, 2019 — Mentice AB, provider of endovascular performance solutions, has signed an agreement with the nonprof
Ethicon Launches Global Liver Lesion Ablation Registry
News | Interventional Radiology | April 10, 2019
Johnson & Johnson Medical Devices Companies announced Ethicon has launched a new global registry to collect and...